Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

2(33.3%)

Phase 2

2(33.3%)

N/A

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 1(2)

Phase 2(2)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02413645Phase 1Completed

Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients

Role: lead

NCT03789825Completed

Population-based Study in Screening for Liver Fibrosis

Role: lead

NCT04329650Phase 2Completed

Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia

Role: lead

NCT04492995Phase 2Unknown

Sentinel Node in Endometrial Cancer

Role: lead

NCT04416906Phase 3Completed

A Test and Treat Strategy in New HIV Diagnosis.

Role: lead

NCT02362880Not ApplicableTerminated

Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study

Role: lead

NCT02767193Phase 1Completed

Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected Patients

Role: lead

All 7 trials loaded